Wait, what? The reported mOS values are different this year than last year? I thought it was always 59 weeks for high dose Ph2 cohort, 32 weeks for low dose Ph2 cohort, and 32 weeks for the historical pooled analysis. Did I miss something?
If you were referring to something other than rGBM (ie. OVCA), I definitely have not care much for that right now.
Market Data 
Markets 
